Latest round

Seed

Last raised

Dec 2021

Total raised

$46M

Investors

7

About Replay

, aka Replay operates as a biotechnology company. The company was founded by its Executive Chairman, and President, Adrian Woolfson, Chief Executive Officer Lachlan MacKinnon, Ron Weiss, and David Knipe. Replay develops a range of immune silencing technologies called uCell™, synHSV™, DropSynth™, and Learned Ancestral Sequence Recognition (LASR) which can be used to rewrite and optimize gene sequences, create polygenic medicine, and develop DNA-based treatments to treat rare diseases like solid tumors and polygenic diseases that affect the skin, eye, brain, and muscle. The company's hypoimmunogenic technique can be used to develop affordable cell treatments that target illnesses by creating allogeneic donor-derived primary cells and iPSCs (induced pluripotent stem cells).

Who invested in Replay

7 investors across 1 round

See all investors in Replay

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Dec 13, 2021

    Amount

    $46M

    Investors

    Locked

Questions about Replay

Who invested in Replay?

Replay has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Replay raised?

Replay has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Replay last raise money?

Replay's most recent round on record is a Seed, in Dec 2021.

What does Replay do?

, aka Replay operates as a biotechnology company.

Where is Replay headquartered?

Replay is headquartered in San Diego, US.

Which VCs invest in companies like Replay?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Replay's stage. Their profiles are linked below.

Raising like Replay? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.